© 2016 Kelly:Feber Lab

  • Grey Facebook Icon
  • Grey Twitter Icon

THE TEAM

Professor John Kelly

Professor John Kelly is a consultant urological surgeon specialising in robotic surgery for bladder and prostate cancer. He is the lead for the London Cancer Urology Surgery Centre and the robotic surgery programme at University College London Hospitals (UCLH).

Dr Andy Feber

Dr Andy Feber is Senior Lecturer in the Division of Surgery and Interventional Science at UCL, and leads the genomics research within the Kelly:Feber Lab. Utilising the latest technologies, the aim of Dr Feber’s research is to define the genomic and epigenomic alterations involved in cancer development and progression and how these alterations can be used in the diagnosis and treatment of cancer.

Dr Patricia de Winter

Dr de Winter originally trained as a nurse and specialised in urology. She then changed career and entered academia completing a Master’s in Physiology followed by a Ph.D.  She now specialises in qPCR. She previously  worked as BHF Junior Research Fellow at King’s College London and taught undergraduates and postgraduates at Birkbeck, University of London as a Sessional Lecturer.

Dr Liqin Dong

Dr Dong’s academic background is in Molecular Biology, Genomics, and Next Generation Sequencing (NGS). I currently work on the UroMark project, and some projects of developing targeted panel  using NGS and other technologies for clinical diagnostic purpose.

 

Before joining UCL, I worked as a Senior Scientist NGS, in the biotechnology industry, Oxford Gene Technology where I worked in High Throughput NGS Service and then development of NGS products compatible with leading NGS platforms.

Ms Sheida Rezaee

Sheida obtained her M.Sc. in Biomedical and Molecular Sciences Research at King’s College London, having previously secured her B.Sc. in Cellular and Molecular Biology in Iran.  She has many years of cancer and biomedical research experience.

Since 2002 Sheida has specialised in molecular biology and cellular immunology techniques as a research assistant at King’s College, University College London, and in the Cancer Research Laboratory at the University of New South Wales, Australia.  She is currently working on projects focused on investigating of the utility of epigenetic alterations as non-invasive biomarkers for the detection of urological cancers.

View UCL IRIS profile

Dr Simon Rodney

Dr Simon Rodney obtained his medical degree from the University of Cambridge and is currently an academic urology trainee. His Ph.D. involves studying the molecular biology of penile cancer and the role of cell free DNA in detecting lymph node metastases in urological malignancies.

Dr Wei Shen Tan

Dr Wei Shen Tan is a Urology Foundation Research Fellow at UCL and Honorary Urology Registrar at UCLH. He was previously as Academic Clinical Fellow (ACF) in Urology also at UCL. His research interest includes urological oncology outcomes and translational research. He is pursuing a higher degree in translational bladder cancer trials.

Dr Pramit Khetrapal

Dr Pramit Khetrapal trained in medicine at UCL. He is currently working on the development of blood-based biomarkers for use in patients  who have undergone cystectomy for bladder cancer.

 

Tumour DNA in serum and plasma could be an early warning of cancer recurrence, before these lesions are big enough to see on conventional imaging. This would permit early and more targeted treatment of disease with conventional chemotherapy and newer immunotherapy drugs. 

Frelyn Ocampo

Frelyn was an experienced senior staff nurse in general surgery at UCLH for 14 years before joining the Cancer Clinical Trials Unit and working on prostate cancer trials. She has recently taken over bladder cancer trials  working on DETECT-1 and DETECT-2 - a study protocol for a prospective multi-centre observational study to validate the UroMark assay to detect bladder cancer from urine samples. She works on the HIVEC-II trial and is involved in recruiting participants on the CALIBER and PHOTO trials.

Please reload